prostate cancer biomarker - Yahoo Search Results

Ads
related to: prostate cancer biomarker
Physicians: An nmCRPC Therapy - nmCRPC Treatment Information

www.treatingadvancedprostatecancer.com
If Your Patient's PSA Levels Rise While On A Hormone Therapy, He May Be At Risk Of nmCRPC.
Patient Profiles · $0 Co-Pay Available · Clinical Information · Clinical Nurse Educators
nmCRPC Treatment Option
31% Risk of Death Decrease

Visit The Patient Site.

Dosing & Administration
View Recommended Dosage & Learn

About Drug Interactions Here.

mHSPC Treatment Option
32% Risk of Death Decrease

Visit The Patient Site.

Clinical Information
Read About A Double-Blind, Placebo-

Controlled, Randomized Study.

Downloadable Resources
Resources For Physicians & Patients

Available On The Site To Download.

Representatives Available
Stay Informed And Get More Info

From A Team Of Representatives.
Genetic Testing For Cancer - Hereditary Cancer Genetic Test

www.invitae.com
invitae.com has been visited by 10K+ users in the past month
Empower confident care planning via actionable inherited cancer risk insights from Invitae. Invitae is a leading cancer genetics company chosen by 4M+ patients and providers.
Online Ordering · Comprehensive Test Menu · Simple Pricing & Billing
Types: Genetic Testing, Genetic Counseling, Guide Patient Care

Search results

- Surveillance is an Effective Way to Manage Some Types of Prostate Cancer, New Study Finds
  Healthline via AOL· 2 days ago
  A new study finds that for people with low-grade prostate cancer, active surveillance is effective...
- More Evidence Backs Active Surveillance for Low-Risk Prostate Cancer
  MedPage Today· 3 days ago
  Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after...
- Study Shows Polygenic Risk Score (PGS) Could Predi | Newswise
  Newswise· 3 days ago
  Data from a large prospective cohort study reveal that a polygenic risk score has the potential to...
- Study Reveals Worse Clinical Outcomes in Breast Ca | Newswise
  Newswise· 3 days ago
  Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who...
- Study shows overlooked lipid is connected to ancient cellular pathway with links to cancer
  Medical Xpress· 4 days ago
  Brooke Emerling, Ph.D., co-director of and associate professor in the Cancer Metabolism and Microenvironment Program at Sanford Burnham Prebys, is contributing to a revival ...
- Small Business - Shelby County Reporter | Shelby County Reporter
  The Shelby County Reporter· 1 day ago
  ConcertAI introduces predictive and generative AI solutions powered by multi-modal real-world data, key partnerships, CARA AI, and more at the 2024 ASCO Annual Meeting PR Newswire CAMBRIDGE, Mass., May 31, 2024 Solutions enable both research and
- Small Business - The Andalusia Star-News | The Andalusia Star-News
  The Andalusia Star-News· 5 days ago
  Global Immunoassay Market to Witness Growth at a CAGR of ~8% by 2030 | DelveInsight PR Newswire LAS VEGAS, May 27, 2024 The surge in the immunoassay market is mainly from the rising occurrence ...
- Mercy Bioanalytics Pushing Forward with Plans to Market Ovarian Cancer Blood Test
  GenomeWeb News· 4 days ago
  Extracellular vesicle diagnostics firm Mercy Bioanalytics is making progress in its plans to market and eventually garner US Food and Drug Administration approval for a novel ovarian
- GGB Research Day Showcases Work of Students and Labs
  UB Reporter· 4 days ago
  Ephraim J. Gardner, with his award-winning research poster for his study titled “Investigating Novel Players Involved in AR Cistrome Reprogramming.” Students and laboratories affiliated with ...